US Bancorp’s Oric Pharmaceuticals ORIC Stock Holding History

US Bancorp’s Portfolio ORIC Stock Details ORIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.19K	Buy	+173	New	+$1.96K	﹤0.01%	3785
2025 Q4	–	Sell	-34	Closed	-$408	–	4165
2025 Q3	$408	Buy	34 +6	+21%	+$63	﹤0.01%	3890
2025 Q2	$284	Buy	28 +6	+27%	+$40	﹤0.01%	4046
2025 Q1	$123	Sell	22 -5	-19%	-$44	﹤0.01%	4133
2024 Q4	$218	Buy	+27	New	+$248	﹤0.01%	4076
2022 Q2	–	Sell	-69	Closed	–	–	4177
2022 Q1	$0	Sell	69 -943	-93%	-$8.49K	﹤0.01%	4165
2021 Q4	$15K	Sell	1,012 -343	-25%	-$5.35K	﹤0.01%	3267
2021 Q3	$28K	Buy	+1,355	New	+$27.5K	﹤0.01%	2949

Other funds holding ORIC

Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

SOCM

SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return

Pfizer New York $239M AUM 232.47% 1-Year Est. Return

Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

US Bancorp's ORIC Position: Q1 2026 in Review

US Bancorp opened a new position in Oric Pharmaceuticals (ORIC) in Q1 2026: 173 shares worth $2.19K. The stake represents ﹤0.01% of the portfolio and ranks #3785 among its holdings. This is a return to the name: US Bancorp previously reported a position in ORIC as recently as Q3 2025.

US Bancorp first reported a position in ORIC in Q3 2021 and has held it in 8 quarters since. The position peaked at $28K in Q3 2021. 182 funds tracked by Wall St. Rank hold ORIC as of Q1 2026.

US Bancorp held 173 shares of Oric Pharmaceuticals worth $2.19K as of Q1 2026.
Oric Pharmaceuticals was a new US Bancorp position in Q1 2026.
Oric Pharmaceuticals made up ﹤0.01% of US Bancorp's portfolio in Q1 2026, its #3785 holding.
US Bancorp first reported a position in Oric Pharmaceuticals in Q3 2021 and has held it in 8 quarters since.
US Bancorp's Oric Pharmaceuticals position peaked at $28K in Q3 2021.
182 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q1 2026.

Based on US Bancorp's 13F filing for Q1 2026, filed 15 May 2026.